#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital ectodermal dysplasia Fabry's disease Mucous membrane pemphigoid Waldenstrom's macroglobulinaemia Richter's syndrome Idiopathic inflammatory myopathy Squamous cell carcinoma of head and neck Skin angiosarcoma Osteosarcoma Pleural mesothelioma malignant PIK3CA-activated mutation Acute myeloid leukaemia refractory T-cell lymphoma Proteus syndrome Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Ocular melanoma – Treatment Glycogen storage disease type I – Life with Disease Mantle cell lymphoma refractory – Basic Information Optic glioma – Life with Disease Aicardi-Goutieres syndrome – Life with Disease Von Willebrand’s disease – Diagnostics Hairy cell leukaemia – Diagnostics Activated PI3 kinase delta syndrome – Basic Information Small intestine leiomyosarcoma Gastrointestinal stromal tumour More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pertuzumab Cloxacillin Sodium Pazopanib Tazobactam Doxycycline Cortisone Acetate Sodium Thiosulfate Docetaxel Daunorubicin VELPATASVIR Camonsertib Ublituximab Burfiralimab Bepranemab Monalizumab Furosemide Dexamethasone Acetate Depemokimab Bio89-100 Avalglucosidase Alfa More therapies…

    Learn about Your Condition

    Fibrosarcoma metastatic Sepsis Colonoscopy Cerebral haemorrhage Ewing's sarcoma Alveolar rhabdomyosarcoma Ehlers-Danlos syndrome Pneumonia Primary hypogonadism Hereditary optic atrophy Craniocerebral injury Pemphigoid Haemodynamic instability Osteochondrodysplasia Breast conserving surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of LY3537982 for Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • 2-AMINO-4-[(4AS)-8-CHLORO-10-FLUORO-2,3,4,4A,5,6-HEXAHYDRO-12-OXO-3-(1-OXO-2-PROPEN-1-YL)-1H,12H-PYRAZINO[2,1-D][1,5]BENZOXAZOCIN-9-YL]-7-FLUORO-BENZO[B]THIOPHENE-3-CARBONITRILE
    • Ly3537982
    • Cetuximab
    France

  • Study of Axitinib and Etoposide for Children and Young Adults with Refractory or Relapsing Medulloblastoma and Ependymoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ependymoma malignant
    • Medulloblastoma recurrent
    Investigated Drugs:
    • Axitinib
    • Etoposide
    France

  • Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
    • Clostridia, Cluster Xiva, Strain Relative Blautia Sp001304935, Live
    • Clostridia, Cluster Xiva, Strain Relative Dorea_A Longicatena, Live
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mexiletine Hydrochloride
    Belgium Denmark Germany Italy Spain

  • Study of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Regn7075
    • Carboplatin
    • Cemiplimab
    France Germany Spain

  • Study on the Effects of Landiolol Hydrochloride for Patients with Microcirculatory Issues During Septic Shock

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Landiolol Hydrochloride
    France
Previous Page
1 … 394 395 396 397 398 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!